World Health Organization. Global Burden of Mental Disorders and the Need for a Comprehensive, Coordinated Response from Health and Social Sectors at the Country Level. WHO; 2011.
2.
RahmanRSheehanDJavedA, et al. The National Psychiatric Morbidity Survey of Pakistan (2022): prevalence, socio-demographic and disability correlates. medRxiv. Published online 2024. doi:10.1101/2024.07.08.24310056
3.
McIntyreRSAlsuwaidanMBauneBT, et al. Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatr. 2023;22(3):394-412.
4.
Main ThompsonASaleemSM. Closing the mental health gap: transforming Pakistan’s mental health landscape. Front Health Serv. 2024;4:1471528.
5.
ReifAAnıl YağcıoğluAELutsA, et al. Esketamine nasal spray shows higher remission and response rates over 32 weeks of treatment compared with quetiapine extended-release in patients with treatment resistant depression: results from ESCAPE-TRD, a randomised, phase IIIb clinical trial. Eur Psychiatr. 2023;66(S1): S90-S91.
6.
ReifABitterIBuyzeJ, et al. Esketamine nasal spray versus quetiapine for treatment-resistant depression. N Engl J Med. 2023;389(14):1298-1309.
7.
MoleroPRamos-QuirogaJAMartin-SantosRCalvo-SánchezEGutiérrez-RojasLMeanaJJ. Antidepressant efficacy and tolerability of ketamine and esketamine: a critical review. CNS Drugs. 2018;32(5):411-420.
8.
DumanRSAghajanianGKSanacoraGKrystalJH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med. 2016;22(3):238-249.
9.
Muhammad GaditAAMugfordG. Prevalence of depression among households in three capital cities of Pakistan: need to revise the mental health policy. PLoS One. 2007;2(2):e209.
10.
KhanMNAkhtarPIjazSWaqasA. Prevalence of depressive symptoms among university students in Pakistan: a systematic review and meta-analysis. Front Public Health. 2020;8:603357.
11.
KhanFAAhmedSSiddiquiAA. The role of perceived social support in moderating the relationship between postpartum depression and mental health in urban Pakistan. Behav Sci. 2021;11(2):53.
12.
MahmoodAKhanMASaeedMAshrafSKhanI. Tolerance and acceptability of intravenous ketamine therapy for treatment-resistant depression: a mixed methods assessment. J Pak Psychiatr Soc. 2023;20(1):45-54.
